Services

Translational Science

NDA Advisory Board

Regulatory Affairs

Pharmaco-
vigilance

High-Stakes Meetings

Health Technology Assessment

Spotlight

Brexit Impact

Are you ready?

More

More Spotlight Videos

News

Immunogenicity for investigational biopharmaceutical products – Start with the goal in mind

15th November 2018

NDA invites to lunch seminar in Cambridge where Paul Chamberlain speaks on anticipating and avoiding issues for biopharmaceutical development.

More

What Do Providers Need to Know About Biosimilars?

9th November 2018

With a number of new biosimilars making their way to market and eventually to the clinic, it is crucial that healthcare providers become educated about and comfortable with biosimilar products. During a session at the fifth DIA Biosimilars Conference, held October 22 to 23 in London, United Kingdom, experts addressed a number of key areas for provider education.

More

Interactions with the Agencies during development

8th November 2018

Welcome to NDA’s free breakfast seminar on 4th December 8:30 – 10:00 about ‘Interactions with the Agencies during development’.

More

Pharmacovigilance Audits and Inspections Summit – November 7, 2018

6th November 2018

Shelley Gandhi has been invited to present a session at the Pharmacovigilance Audits and Inspections Summit – November 7, 2018 • Wyndham Philadelphia Historic District • Philadelphia, PA

More

Free Webinar – How to demonstrate value in drug development programs to improve chances of reimbursement

5th November 2018

Join us on Thursday 29th November for this engaging webinar with Claes Buxfeldt, HTA Director.

More

NDA Group expands presence in Denmark

1st November 2018

In time for the European BIO meeting in Copenhagen NDA is expanding the physical presence in Denmark. With the appointment of Katja Gustafsson as Senior Consultant NDA will be working closely with clients in the region.

More

Recommendations from PRAC – Insights and implementation

24th October 2018

NDA invites to breakfast seminar where Shelley Gandhi speaks on recommendations from PRAC – insights and implementation.

More
More News
We have helped over 2,000 clients achieve success in the past
We have helped over 2,000 clients achieve success in the past

The leader in FDA Advisory Committee meeting preparation

“For innovative life science companies, NDA and PharmApprove are the best partners to help prepare to win at FDA Advisory Committees. Our pioneering approach — refined over 16 years experience and 150-plus projects — has helped more than 80 clients achieve success at these high-profile, high-stakes hearings.

NDA Intelligence

Subscribe to the latest intelligence from the true thought leaders in the field and access it at any time.

Members

A Career with NDA

Join NDA and get the chance to work with some of the leading minds in regulatory affairs, pharmacovigilance, health technology assessment and scientific communications on a variety of projects, clients and geographies.

Join NDA and get the chance to work with some of the leading minds in regulatory affairs, pharmacovigilance,

Why work at NDA?

Our Locations

NDA Sweden

NDA Group AB
Johanneslundsv. 2
S-194 61 Upplands Väsby
Sweden

T. +46 (0)8 590 778 00
E. stockholm@ndareg.com

NDA France

7, rue Jobbé Duval,
75015 Paris,
France

T. +33 983 981 942
E. paris@ndareg.com

NDA Germany

Neumarkter Straße 18
D-81673 München
Germany

T. +49 (0)89 3585 4000
E. munich@ndareg.com

NDA Switzerland

Rigistrasse 5
8703 Erlenbach
Switzerland

T. +41 (0)78 951 9929
E. zurich@ndareg.com

NDA UK

Grove House
Guildford Road
Leatherhead,
Surrey KT22 9DF
United Kingdom

T. +44 (0) 1372 860 610
E. london@ndareg.com

NDA USA Massachusetts

NDA Regulatory Development Inc.
1 Broadway, 14th floor
Cambridge, MA 02142
United States

T. +1 609 583 1990
E. usa@ndareg.com

NDA USA New Jersey

PharmApprove
200 Princeton South Corporate Center,
Suite 340
Ewing, NJ 08628
United States

T. +1 609 583 1990
E. usa@ndareg.com